Omar Sued
Overview
Explore the profile of Omar Sued including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
2464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez Y, Marson M, Fernandez M, Sued O, Frola C, Perez Lloret S, et al.
Mem Inst Oswaldo Cruz
. 2025 Mar;
120:e240177.
PMID: 40052995
Background: Benznidazole (BNZ) is the primary treatment for Chagas disease. While pharmacokinetic studies of BNZ began in the 1970s, its metabolism and excretion are not fully understood. Alternatives like Benznidazol...
2.
Sued O, Rodriguez V, Weiss S, Alcaide M, Cecchini D, Cahn P, et al.
Int J Behav Med
. 2025 Feb;
PMID: 39994143
Background: Although Argentina provides access to no cost HIV care, treatment adherence and retention in care remain suboptimal. This study aimed to explore factors associated with self-reported adherence and appointment...
3.
Ford N, Kassanjee R, Stelzle D, Jarvis J, Sued O, Perrin G, et al.
J Int AIDS Soc
. 2025 Feb;
28(2):e26415.
PMID: 39915008
Introduction: Recent studies have indicated a high enduring burden of advanced HIV disease, but estimates across regions and settings are lacking. The aim of this study was to estimate the...
4.
Sebro A, Edwards J, Sued O, Lavia L, Elder T, Edwards R, et al.
J Fungi (Basel)
. 2024 Dec;
10(12).
PMID: 39728391
In the original publication [...].
5.
Lee J, Sued O, Ribeiro I, Jarvis J, Burry J
Lancet Glob Health
. 2024 Dec;
13(1):e24.
PMID: 39706655
No abstract available.
6.
Falci D, Pasqualotto A, Vieceli T, Sued O, Reis N, Soares R, et al.
HIV Med
. 2024 Dec;
26(3):427-433.
PMID: 39657975
Objectives: To evaluate the performance of Xpert MTB/RIF Ultra testing in urine samples as part of a TB screening strategy in patients with advanced HIV disease (AHD). Methods: We conducted...
7.
Costa A, Dos Santos Boeira L, de Almeida-Segundo D, Chaves L, Sainz L, Silva L, et al.
PLoS One
. 2024 Nov;
19(11):e0312204.
PMID: 39602400
The rapid diagnosis of opportunistic infections (OIs) is critical for improving the health outcomes of people living with HIV/AIDS (PLWHA). This study aimed to describe the feasibility of implementing a...
8.
Morey F, Giron-Callejas A, Manzanero R, Urbina A, Garcia-Morales C, Joseph J, et al.
J Antimicrob Chemother
. 2024 Nov;
80(1):292-300.
PMID: 39556256
Background: The rising prevalence of pretreatment drug resistance (PDR) to non-nucleoside reverse-transcriptase inhibitors threatens the effectiveness of ART. In response, the WHO recommends dolutegravir-based ART regimens due to their high...
9.
Cortes C, Sued O, Wong W, Borquez A, Ssonko C, Parczewski M, et al.
Lancet HIV
. 2024 Nov;
11(12):e861-e872.
PMID: 39536774
Displaced populations living with HIV, including refugees and asylum seekers, face substantial challenges across various regions globally. The intersection of forced migration and HIV presents both shared challenges and region-specific...
10.
Sebro A, Edwards J, Sued O, Lavia L, Elder T, Edwards R, et al.
J Fungi (Basel)
. 2024 Oct;
10(10).
PMID: 39452647
The Caribbean continues to have high HIV prevalence globally with concurrently high mortality rates due to opportunistic Infections. This study addresses the prevalence of histoplasmosis and cryptococcosis among patients living...